FDA Issues Update on Safety Review of Orlistat (Alli and Xenical)
Liver Damage Reported
The FDA is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat. Orlistat is marketed in the United States as a prescription product, Xenical, and as an over-the-counter (OTC) product, Alli.
Between 1999 and October 2008, 32 reports of serious liver injury, including 6 cases of liver failure, in patients using orlistat were submitted to FDA’s Adverse Event Reporting System. Thirty of the 32 reports occurred outside the United States. The most commonly reported adverse events described in the 32 reports of serious liver injury were jaundice (yellowing of the skin or whites of the eyes), weakness, and abdominal pain. Hospitalization was reported in 27 of the 32 cases.
Xenical (orlistat 120mg) was approved as a prescription product by FDA in 1999 for obesity management in conjunction with a reduced caloric diet, and to reduce the risk of regaining weight after prior weight loss. In 2007, Alli (orlistat 60mg) was approved for OTC use for weight loss in overweight adults, 18 years and older, in conjunction with a reduced-calorie and low-fat diet. Currently, orlistat is approved for marketing in approximately 100 countries. In January 2009, a nonprescription version of orlistat was approved for sale in the European Union.
AUG-24-09: FDA Issues Update on Safety Review Orlistat [FDA: LIVER DAMAGE REPORTED WITH ORLISTAT]
Legal Help
If you or a loved one has suffered adverse health effects from using this drug, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Related Law Suits
FDA Issues Update on Safety Review Orlistat Law Suit and Settlement
FDA Issues Early Safety Communication About Meridia Diet Pill Law Suit and Settlement
FDA Issues Safety Warning About Valproic Acid and Divalproex Sodium Law Suit and Settlement
UPDATE 1: Caraco Digoxin Recall Law Suit and Settlement
FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes Law Suit and Settlement
Health Canada Issues Warning Law Suit and Settlement
FDA Issues Warning about Promethazine Hydrochloride Injection Law Suit and Settlement
FDA Issues Warning Regarding Topical Ibuprofen Drug Products Law Suit and Settlement
Clopidogrel Marketed as Plavix FDA Issues Public Health Advisory Law Suit and Settlement
FFDA Issues Warning about Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution Law Suit and Settlement
See more stories from this source.
Class Action Law Suits
Newsworthy Law Suits
Defective Products Lawsuits
Discrimination Lawsuits
Drug & Medical Claims Lawsuits
Food & Dietary Supplement Lawsuits
Insurance Lawsuits
Malpractice Lawsuits
Personal Injury Lawsuits
Real Estate Lawsuits
Investment Fraud Lawsuits
Related Law Articles
is===1Related Law Questions
Related Law Bulletins
Lawyers! Become an Approved Expert to Answer Questions.
Apply Now!
You'll get lots of targetted traffic to your website and new client leads!